logo

For the Inventor, By the Inventor

Berlin, Germany

Martin Quanz

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Polysaccharide Production. Top assignees: Bayer Bioscience Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Celanese Ventures Gmbh. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Quanz. Retrieved from https://idiyas.com/inventor/martin-quanz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 50.0



Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 89(Granted Patents)


Company Filing History:

goldMedal8 out of 16 
 
Bayer Bioscience Gmbh
 patents
silverMedal3 out of 1,335 
 
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.
 patents
bronzeMedal2 out of 31 
 
Celanese Ventures Gmbh
 patents
4. 1 out of 1,036 
 
Bayer Cropscience Ag
 patents
5. 1 out of 10 
 
Planttec Biotechnologie Gmbh
 patents
6. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hyaluronan
Polysaccharides
Glucans
Amylosucrase
Nucleic Acids
Genetically Modified Plants
Alternansucrase
Enzyme Activity
Production Methods
Food Applications
Branching Enzyme
14 patents (USPTO):Explore Patents
1. 8975064 - Methods and means for producing hyaluronan (2015-03-10),
2. 8771424 - Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose (2014-07-08),
3. 8716463 - Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose (2014-05-06),
4. 7833751 - Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose (2010-11-16),
5. 7732164 - Method for producing α-1, 6-branched α-1, 4-glucans from sucrose (2010-06-08),
6. 7666632 - Nucleic acid molecules encoding alternansucrase (2010-02-23),
7. 7666623 - Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose (2010-02-23),
8. 7638311 - Method for producing α-1, 6-branched α-1, 4-glucans from sucrose (2009-12-29),
9. 7402420 - Nucleic acid molecules encoding alternansucrase (2008-07-22),
10. 6699694 - Method for producing &agr;-1,6-branched &agr;-1,4-glucans from sucrose (2004-03-02),
11. 6696563 - &agr;-Amylase-resistant polysaccharides, production method, use and foods containing these polysaccharides (2004-02-24),
12. 6677142 - Polysaccharides containing &agr;-1,4-glucan chains and method for producing same (2004-01-13),
13. 6570065 - Nucleic acid molecules encoding alternansucrase (2003-05-27),
14. 6566585 - Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme (2003-05-20),

Title: Inventor Martin Quanz

Introduction: Martin Quanz is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Martin Quanz holds several patents in the areas of renewable energy, sustainable transportation, and smart city solutions, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Martin Quanz has worked with leading research institutions and tech companies to develop cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Martin Quanz has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Martin Quanz continues to be a driving force in the world of innovation, with his passion for creating a sustainable future evident in all his inventions and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…